據歐盟食品安全局（EFSA ）消息，2022年5月10日，歐盟食品安全局就活性物質淡紫擬青霉（Purpureocillium lilacinum）菌株PL11的農藥風險評估發布同行評審。
經過評估，將淡紫擬青霉菌株PL11作為殺線蟲劑用在番茄、辣椒、茄子、黃瓜、小胡瓜、甜瓜、西瓜和南瓜（田間和溫室應用）的基礎上，歐盟食品安全局提出了適用于監管風險評估的可靠端點，列出了監管框架要求的缺失信息。部分原文報道如下：
The conclusions of the EFSA following the peer review of the initial risk assessments carried out by the competent authority of the rapporteur Member State, the United Kingdom, for the pesticide active substance Purpureocillium lilacinum strain PL11 and the considerations as regards the inclusion of the substance in Annex IV of Regulation (EC) No 396/2005 are reported. The context of the peer review was that required by Regulation (EC) No 1107/2009 of the European Parliament and of the Council. The conclusions were reached on the basis of the evaluation of the representative uses of Purpureocillium lilacinum strain PL11 as nematicide on tomato, pepper, aubergine, cucumber, courgette, melon, watermelon, pumpkin (field and greenhouse applications). The reliable endpoints appropriate for use in regulatory risk assessment are presented. Missing information identified as being required by the regulatory framework is listed.
經過評估，將淡紫擬青霉菌株PL11作為殺線蟲劑用在番茄、辣椒、茄子、黃瓜、小胡瓜、甜瓜、西瓜和南瓜（田間和溫室應用）的基礎上，歐盟食品安全局提出了適用于監管風險評估的可靠端點，列出了監管框架要求的缺失信息。部分原文報道如下：
The conclusions of the EFSA following the peer review of the initial risk assessments carried out by the competent authority of the rapporteur Member State, the United Kingdom, for the pesticide active substance Purpureocillium lilacinum strain PL11 and the considerations as regards the inclusion of the substance in Annex IV of Regulation (EC) No 396/2005 are reported. The context of the peer review was that required by Regulation (EC) No 1107/2009 of the European Parliament and of the Council. The conclusions were reached on the basis of the evaluation of the representative uses of Purpureocillium lilacinum strain PL11 as nematicide on tomato, pepper, aubergine, cucumber, courgette, melon, watermelon, pumpkin (field and greenhouse applications). The reliable endpoints appropriate for use in regulatory risk assessment are presented. Missing information identified as being required by the regulatory framework is listed.
